Cortactin Modulates RhoA Activation and Expression of Cip/Kip Cyclin-Dependent Kinase Inhibitors to Promote Cell Cycle Progression in 11q13-Amplified Head and Neck Squamous Cell Carcinoma Cells

Molecular and Cellular Biology - United States
doi 10.1128/mcb.00249-10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

EGFR Modulates Complement Activation in Head and Neck Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Cyclin D1 Polymorphism and Expression in Patients With Squamous Cell Carcinoma of the Head and Neck

American Journal of Pathology
Forensic MedicinePathology
2001English

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma

Methods in Molecular Biology
GeneticsMolecular Biology
2009English

Expression of a Novel mRNA in Human Head and Neck Squamous Cell Carcinoma Cells.

Molecular Pathology
1997English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Mutations of the LIM Protein AJUBA Mediate Sensitivity of Head and Neck Squamous Cell Carcinoma to Treatment With Cell-Cycle Inhibitors

Cancer Letters
Cancer ResearchOncology
2017English

Aberrant Expression of Cortactin in Head and Neck Squamous Cell Carcinoma Cells Is Associated With Enhanced Cell Proliferation and Resistance to the Epidermal Growth Factor Receptor Inhibitor Gefitinib

Cancer Research
Cancer ResearchOncology
2007English

Role of Phosphatidylinositol-3-Kinase Pathway in Head and Neck Squamous Cell Carcinoma

Journal of Oncology
Oncology
2012English

Understanding Genetic Progression of Squamous Cell Carcinoma to Spindle Cell Carcinoma in a Mouse Model of Head and Neck Cancer

International Journal of Oncology
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy